Robert Shenkar to Integrin beta1
This is a "connection" page, showing publications Robert Shenkar has written about Integrin beta1.
Connection Strength
0.056
-
ß1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations. FASEB J. 2022 12; 36(12):e22629.
Score: 0.056
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.